Switching from natalizumab to anti-CD20 monoclonal antibodies: optimal timing and safety analysis

被引：0
|
作者：
Levin, S. [1 ]
Levine, L. [1 ]
Vargas, W. [1 ]
Straus-Farber, R. [1 ]
De Jager, P. [1 ]
Riley, C. [1 ]
机构：
[1] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P670
引用
收藏
页码：333 / 333
页数：1
相关论文
共 50 条
  • [11] Characteristics of Patients Switching from Anti-CD20 Therapy to Natalizumab in the Treatment of Multiple Sclerosis
    Vollmer, Brandi
    Nair, Kavita
    Corboy, John
    Vollmer, Timothy
    Alvarez, Enrique
    [J]. NEUROLOGY, 2019, 92 (15)
  • [12] All anti-CD20 monoclonal antibodies have similar efficacy and safety risks: Yes
    Cree, Bruce A. C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (12) : 1843 - 1844
  • [13] Challenges of switching towards anti-CD20 monoclonal antibodies in RR-MS: A monocentric study
    de la Motte, Marine Boudot
    Louapre, Celine
    Papeix, Caroline
    Depaz, Raphael
    Assouad, Rana
    Roux, Thomas
    Lubetzki, Catherine
    Maillart, Elisabeth
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [14] Challenges of initiating anti-CD20 monoclonal antibodies in RR MS
    de la Motte, M. Boudot
    Louapre, C.
    Papeix, C.
    Lubetzki, C.
    Maillart, E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 44 - 44
  • [15] Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises
    Bagacean, Cristina
    Zdrenghea, Mihnea
    Tempescul, Adrian
    Cristea, Victor
    Renaudineau, Yves
    [J]. IMMUNOTHERAPY, 2016, 8 (05) : 569 - 581
  • [16] Anti-CD20 monoclonal antibodies: Beyond B-cells
    Avivi, Irit
    Stroopinsky, Dina
    Katz, Tamar
    [J]. BLOOD REVIEWS, 2013, 27 (05) : 217 - 223
  • [17] Treatment of posttransplantation diabetes mellitus with anti-CD20 monoclonal antibodies
    Vandenbosch, K
    Champagne, MA
    Gonthier, M
    Moghrabi, A
    Vachon, MF
    Duval, M
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 64 - 64
  • [18] Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis
    Finn Sellebjerg
    Morten Blinkenberg
    Per Soelberg Sorensen
    [J]. CNS Drugs, 2020, 34 : 269 - 280
  • [19] Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis
    Sellebjerg, Finn
    Blinkenberg, Morten
    Sorensen, Per Soelberg
    [J]. CNS DRUGS, 2020, 34 (03) : 269 - 280
  • [20] The future of anti-CD20 monoclonal antibodies: are we making progress?
    Alduaij, Waleed
    Illidge, Tim M.
    [J]. BLOOD, 2011, 117 (11) : 2993 - 3001
12345